Navigation Links
Oncologists: How to talk with your pathologist about cancer molecular testing
Date:6/1/2014

As targeted therapies become more available, increasing opportunity exists to match treatments to the genetics of a specific cancer. But in order to make this match, oncologists have to know these genetics. This requires molecular testing of patient samples. An education session presented today at the American Society for Clinical Oncology (ASCO) Annual Meeting 2014 details the challenges in this process and makes recommendations that oncologists can use to ensure their patients' samples are properly tested, helping to pair patients with the best possible treatments.

"The problem is there are lot of technical, logistical steps involved in the process of obtaining and molecularly testing patient samples and each step is a place where things can go wrong," says Dara Aisner, MD, PhD, investigator at the CU Cancer Center and molecular pathologist at the CU School of Medicine. The nature of tissue samples and molecular testing means that miscommunications or mistakes can ultimately render a sample unusable.

For example, Aisner points out that the mechanics of some pathology labs dictates that biopsies performed on a Friday may sit in the preservative formalin until Sunday evening fine for microscopy but potentially detrimental for molecular testing. Or, Aisner says, bone biopsies are commonly treated with decalcification solution to make the sample pliable enough to be cut another technique that negates molecular testing. Or a small sample may be used up during immunohistochemistry testing that may come first in a pathology lab workflow unless mechanisms are put into place to specifically prioritize molecular testing over other evaluations.

"A pathology lab is a high volume environment that's optimized to treat all samples the same way, according to the same protocols. If every time you want molecular testing to be the priority, you have to call and make special arrangements, it can be disruptive. The best solution for oncologists and pathology labs is to set up new norms designed to meet the needs of molecular testing, which is quickly becoming the new paradigm," Aisner says.

Aisner suggests close communication, systems approaches, keeping special requests to a minimum, and patience on the part of requesting oncologists. The key, she says, is writing new institutional protocols to keep pace with the new reliance on molecular testing.

"Oncologists and pathologists both know that molecular testing is becoming an essential piece of cancer care," Aisner says. "The question now is how to best implement this testing in an efficient way that leads to the least disruption and best patient outcomes."


'/>"/>

Contact: Erika Matich
erika.matich@ucdenver.edu
University of Colorado Denver
Source:Eurekalert

Related biology news :

1. Clemson plant pathologist working to raise cucurbit yields, lower production costs
2. What can plants reveal about gene flow? That its an important evolutionary force
3. Intuitions about the causes of rising obesity are often wrong, researchers report
4. Male infertility: Its all about the package
5. Leading cfaed scientists organize international workshop about DNA-based microchips
6. Reconstructed ancient ocean reveals secrets about the origin of life
7. The human food connection: A new study reveals more about our relationship to food
8. What songbirds tell us about how we learn
9. Elevating geosciences in the southeastern US: New ideas about old terranes
10. Neck ribs in woolly mammoths provide clues about their decline and eventual extinction
11. What singing fruit flies can tell us about quick decisions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2016)... 2016 The new GEZE SecuLogic ... web-based "all-in-one" system solution for all door components. It ... the door interface with integration authorization management system, and ... The minimal dimensions of the access control and the ... installations offer considerable freedom of design with regard to ...
(Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
(Date:3/31/2016)... March 31, 2016  Genomics firm Nabsys has completed ... Barrett Bready , M.D., who returned to the ... original technical leadership team, including Chief Technology Officer, ... Development, Steve Nurnberg and Vice President of Software and ... company. Dr. Bready served as CEO of ...
Breaking Biology News(10 mins):
(Date:4/29/2016)... ... , ... Intelligent Implant Systems announced today that the two-level components for the ... United States. These components expand the capabilities of the system and allow Revolution™ ... October of 2015, the company has seen significant sales growth in 1Q 2016, and ...
(Date:4/28/2016)... 28, 2016 Q BioMed ... Company,s CEO  was featured in an article he ... VCs Fear To Tread: http://www.lifescienceleader.com/doc/accelerators-enter-when-vcs-fear-to-tread-0001 ... is an essential business journal for life ... biotechs to Big Pharmas. Their content is designed ...
(Date:4/28/2016)... ... April 28, 2016 , ... As part of an ... experts, and expanding its LATAM network and logistics capabilities. Enhancements have been ... their clinical trial projects. , The expansion will provide unmatched clinical trial logistics ...
(Date:4/27/2016)... ... April 27, 2016 , ... Shimadzu Scientific Instruments (SSI) ... 2016 Marijuana Business Conference and Expo. Shimadzu’s high-performance instruments enable laboratories to test ... Expo attendees can stop by booth 1021 to learn how Shimadzu’s instruments can ...
Breaking Biology Technology: